A genomic-based healthcare business that profiles gut microbes to help people take charge of their wellbeing has been identified as one of Australia’s top startups by a leading global accelerator program.
Microba, which is in the early stages of development at The University of Queensland’s ilab innovation incubator, was named in the top five highest potential startups at the Bridge to MassChallenge Australia competition.
Microba is developing its business through ilab at UQ’s intensive three-month Germinate Program which helps a rich mix of future entrepreneurs develop their diverse business startup ideas.
More than 130 startup companies and their founders have been supported by ilab’s programs since 2012, and more than $17 million in early-stage capital has been raised in the past two years alone.
